China SXT Pharmaceuticals (SXTC) Competitors $2.55 +0.06 (+2.45%) As of 02:53 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock SXTC vs. ADXN, OBSV, BCLI, ONCO, KLTO, CYCN, AYTU, UPC, BTAI, and NKGNShould you be buying China SXT Pharmaceuticals stock or one of its competitors? The main competitors of China SXT Pharmaceuticals include Addex Therapeutics (ADXN), ObsEva (OBSV), Brainstorm Cell Therapeutics (BCLI), Onconetix (ONCO), Klotho Neurosciences (KLTO), Cyclerion Therapeutics (CYCN), Aytu BioPharma (AYTU), Universe Pharmaceuticals (UPC), BioXcel Therapeutics (BTAI), and NKGen Biotech (NKGN). These companies are all part of the "pharmaceutical products" industry. China SXT Pharmaceuticals vs. Addex Therapeutics ObsEva Brainstorm Cell Therapeutics Onconetix Klotho Neurosciences Cyclerion Therapeutics Aytu BioPharma Universe Pharmaceuticals BioXcel Therapeutics NKGen Biotech China SXT Pharmaceuticals (NASDAQ:SXTC) and Addex Therapeutics (NASDAQ:ADXN) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, community ranking, analyst recommendations, earnings, risk, profitability and media sentiment. Do institutionals & insiders hold more shares of SXTC or ADXN? 5.0% of China SXT Pharmaceuticals shares are owned by institutional investors. Comparatively, 16.1% of Addex Therapeutics shares are owned by institutional investors. 4.0% of China SXT Pharmaceuticals shares are owned by company insiders. Comparatively, 15.0% of Addex Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts rate SXTC or ADXN? Addex Therapeutics has a consensus price target of $30.00, indicating a potential upside of 305.41%. Given Addex Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Addex Therapeutics is more favorable than China SXT Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score China SXT Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Addex Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger earnings & valuation, SXTC or ADXN? China SXT Pharmaceuticals has higher revenue and earnings than Addex Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChina SXT Pharmaceuticals$1.93M0.96-$3.10MN/AN/AAddex Therapeutics$556.05K14.11-$11.76M-$0.34-21.76 Does the MarketBeat Community prefer SXTC or ADXN? China SXT Pharmaceuticals received 67 more outperform votes than Addex Therapeutics when rated by MarketBeat users. Likewise, 61.65% of users gave China SXT Pharmaceuticals an outperform vote while only 51.72% of users gave Addex Therapeutics an outperform vote. CompanyUnderperformOutperformChina SXT PharmaceuticalsOutperform Votes8261.65% Underperform Votes5138.35% Addex TherapeuticsOutperform Votes1551.72% Underperform Votes1448.28% Which has more volatility & risk, SXTC or ADXN? China SXT Pharmaceuticals has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500. Comparatively, Addex Therapeutics has a beta of 1.76, meaning that its stock price is 76% more volatile than the S&P 500. Does the media prefer SXTC or ADXN? In the previous week, China SXT Pharmaceuticals had 1 more articles in the media than Addex Therapeutics. MarketBeat recorded 3 mentions for China SXT Pharmaceuticals and 2 mentions for Addex Therapeutics. Addex Therapeutics' average media sentiment score of 1.43 beat China SXT Pharmaceuticals' score of 0.96 indicating that Addex Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment China SXT Pharmaceuticals Positive Addex Therapeutics Positive Is SXTC or ADXN more profitable? Addex Therapeutics has a net margin of 850.30% compared to China SXT Pharmaceuticals' net margin of 0.00%. China SXT Pharmaceuticals' return on equity of 0.00% beat Addex Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets China SXT PharmaceuticalsN/A N/A N/A Addex Therapeutics 850.30%-112.43%-77.95% SummaryAddex Therapeutics beats China SXT Pharmaceuticals on 9 of the 16 factors compared between the two stocks. Remove Ads Get China SXT Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SXTC vs. The Competition Export to ExcelMetricChina SXT PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.85M$6.79B$5.57B$7.84BDividend YieldN/A2.81%5.37%4.05%P/E RatioN/A7.2223.5818.67Price / Sales0.96203.73370.3188.62Price / CashN/A65.6738.1734.64Price / Book0.086.026.654.10Net Income-$3.10M$142.11M$3.20B$246.93M7 Day Performance-17.18%-8.39%-5.81%-3.62%1 Month Performance-43.44%-11.79%-1.02%-6.69%1 Year Performance-80.79%-14.47%7.66%-1.88% China SXT Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SXTCChina SXT Pharmaceuticals1.0457 of 5 stars$2.55+2.4%N/A-81.2%$1.85M$1.93M0.0090ADXNAddex Therapeutics2.8475 of 5 stars$7.69+0.3%$30.00+290.4%-42.7%$8.05M$556,045.00-22.6030Short Interest ↓Gap UpOBSVObsEvaN/AN/AN/AN/A$7.94M$20.11M-0.1150Analyst ForecastNews CoverageBCLIBrainstorm Cell Therapeutics3.8068 of 5 stars$1.37-2.8%$30.00+2,089.8%-85.1%$7.81MN/A-0.2940Upcoming EarningsNews CoverageGap UpONCOOnconetix0.5781 of 5 stars$0.12-6.4%N/A-98.7%$7.73M$1.87M0.0012High Trading VolumeKLTOKlotho NeurosciencesN/A$0.28-3.2%N/AN/A$7.68MN/A0.00N/AEarnings ReportGap DownCYCNCyclerion Therapeutics2.3158 of 5 stars$2.82+2.5%N/A-21.9%$7.64M$2M-2.3130Short Interest ↓Gap UpAYTUAytu BioPharma2.0394 of 5 stars$1.23-0.8%N/A-60.5%$7.59M$77.23M-0.85160UPCUniverse PharmaceuticalsN/A$4.39+24.6%N/A-99.7%$7.53M$26.73M0.00220Gap DownHigh Trading VolumeBTAIBioXcel Therapeutics4.6699 of 5 stars$2.29-1.7%$42.60+1,760.3%-95.5%$7.47M$2.28M-0.0790Earnings ReportShort Interest ↓Gap UpNKGNNKGen BiotechN/A$0.17+6.4%N/A-90.5%$7.42M$80,000.00-0.03N/A Remove Ads Related Companies and Tools Related Companies Addex Therapeutics Alternatives ObsEva Alternatives Brainstorm Cell Therapeutics Alternatives Onconetix Alternatives Klotho Neurosciences Alternatives Cyclerion Therapeutics Alternatives Aytu BioPharma Alternatives Universe Pharmaceuticals Alternatives BioXcel Therapeutics Alternatives NKGen Biotech Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SXTC) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China SXT Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China SXT Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
